Global Cell Harvesting Strategic Market Report 2023-2030: Growing Use of Mesenchymal Stem Cells in Regenerative Medicine to Drive the Cell Harvesting Market
09 oct. 2023 06h03 HE
|
Research and Markets
Dublin, Oct. 09, 2023 (GLOBE NEWSWIRE) -- The "Cell Harvesting - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Cell Harvesting Market to Reach...
Cell Harvesting Global Market to Reach $483.3 Million by 2030: Development of Regenerative Medicine Accelerates Demand for Cell Harvesting
14 avr. 2023 11h13 HE
|
Research and Markets
Dublin, April 14, 2023 (GLOBE NEWSWIRE) -- The "Cell Harvesting: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Cell Harvesting...
Global Cell Harvesting Market Research Report 2022-2026: With Stem Cells Holding Potential to Emerge as Savior for Healthcare System Struggling with COVID-19 Crisis, Demand for Cell Harvesting to Grow
07 avr. 2022 06h53 HE
|
Research and Markets
Dublin, April 07, 2022 (GLOBE NEWSWIRE) -- The "Cell Harvesting - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Cell Harvesting Market...
Insights on the Hematopoietic Stem Cell Transplantation Global Market to 2027 - Key Drivers, Restraints and Opportunities
03 août 2021 05h28 HE
|
Research and Markets
Dublin, Aug. 03, 2021 (GLOBE NEWSWIRE) -- The "Hematopoietic Stem Cell Transplantation (HSCT) Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027" report has been added to...
Outlook on the Cell Therapy Biomanufacturing Global Market to 2025 - by Product Type, Application and Region
22 févr. 2021 06h48 HE
|
Research and Markets
Dublin, Feb. 22, 2021 (GLOBE NEWSWIRE) -- The "Cell Therapy Biomanufacturing: Global Markets" report has been added to ResearchAndMarkets.com's offering. This research report presents an in-depth...
Fate Therapeutics Receives FDA Orphan Drug Designation for ProTmune™ in Allogeneic Hematopoietic Cell Transplantation
26 sept. 2016 08h00 HE
|
Fate Therapeutics, Inc.
SAN DIEGO, Sept. 26, 2016 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and...